1 3 0 VOLUME 17 | NUMBER 1 | JANUARY 2011 naTuRe medicine It remains difficult to distinguish tumor recurrence from radiation necrosis after brain tumor therapy. Here we show that these lesions can be distinguished using the amide proton transfer (APT) magnetic resonance imaging (MRI) signals of endogenous cellular proteins and peptides as an imaging biomarker. When comparing two models of orthotopic glioma (SF188/V+ glioma and 9L gliosarcoma) with a model of radiation necrosis in rats, we could clearly differentiate viable glioma (hyperintense) from radiation necrosis (hypointense to isointense) by APT MRI. When we irradiated rats with U87MG gliomas, the APT signals in the irradiated tumors had decreased substantially by 3 d and 6 d after radiation. The amide protons that can be detected by APT provide a unique and noninvasive MRI biomarker for distinguishing viable malignancy from radiation necrosis and predicting tumor response to therapy.
It remains difficult to distinguish tumor recurrence from radiation necrosis after brain tumor therapy. Here we show that these lesions can be distinguished using the amide proton transfer (APT) magnetic resonance imaging (MRI) signals of endogenous cellular proteins and peptides as an imaging biomarker. When comparing two models of orthotopic glioma (SF188/V+ glioma and 9L gliosarcoma) with a model of radiation necrosis in rats, we could clearly differentiate viable glioma (hyperintense) from radiation necrosis (hypointense to isointense) by APT MRI. When we irradiated rats with U87MG gliomas, the APT signals in the irradiated tumors had decreased substantially by 3 d and 6 d after radiation. The amide protons that can be detected by APT provide a unique and noninvasive MRI biomarker for distinguishing viable malignancy from radiation necrosis and predicting tumor response to therapy.
Advances in surgery, radiation therapy and chemotherapy have improved survival in patients with malignant gliomas. However, the most aggressive malignant gliomas remain universally fatal, with a median survival of about 15 months for glioblastoma multiforme and 2−5 years for anaplastic astrocytoma 1 . MRI is a standard neuroimaging technique. Of the most common MRI approaches used to evaluate brain tumors in the clinical setting, T 2 -weighted or fluid-attenuated inversion recovery (FLAIR) images generally show increased water content in tumors, and gadolinium (Gd)-enhanced T 1 -weighted images indicate blood-brain barrier disruption. In combination, they are used to determine the extent of tumor involvement and to assess the therapeutic response 2 . Although Gd-enhanced MRI is a sensitive marker of blood-brain barrier disruption, it does not distinguish between the many etiologies that can cause such disruption, such as tumor regrowth and radiation necrosis [3] [4] [5] ( Supplementary Fig. 1) . Similarly, T 2 -weighted and FLAIR hyperintensities can indicate many abnormalities, including infiltrating tumors, vasogenic edema and radiation necrosis. Hence, standard MRI sequences provide excellent anatomic detail but are nonspecific.
The ability to distinguish reliably between tumor recurrence and radiation necrosis would have immediate clinical implications. Treatment-induced injury is treated conservatively, whereas tumor recurrence requires the use of additional anticancer therapies. Currently, the only reliable way to differentiate between these etiologies is surgical tissue sampling, which is invasive and not always feasible. Even when surgery is possible and advised, choosing the area to target for tissue sampling can be very difficult, and pathology results may be variable because gliomas are heterogeneous. Various advanced MR techniques [6] [7] [8] [9] and nuclear medicine approaches 10, 11 are being investigated in efforts to identify a more accurate imaging marker for tumors. However, the results have been mixed, and there is still no standard imaging modality available for differentiating tumors from radiation injury in the clinic 2 . Therefore, the development of imaging modalities that better identify targets for biopsy to improve diagnostic yield and reliably identify progressive tumor from various stages of treatment injury noninvasively remains an urgent need in neuro-oncology [12] [13] [14] [15] .
Recently, a new contrast mechanism for MRI, called chemical exchange-dependent saturation transfer 16 , has emerged [17] [18] [19] . On the basis of this mechanism, we have designed a specific chemical exchange-based saturation transfer MRI technique, APT imaging 20 , which can be used to detect the amide protons of endogenous, lowconcentration mobile proteins and peptides in tissue 21 , such as those in the cytoplasm. Malignant gliomas are highly cellular and have a higher cellular content of proteins and peptides than healthy tissue, as revealed by MRI-guided proteomics 22 and in vivo MR spectroscopy 23 . Here we show that the amide protons detected by APT provide an imaging biomarker that can distinguish between tumor and radiation necrosis noninvasively in animal models, where controlled radiopathologic correlation can be readily performed. Because APT imaging does not require exogenous contrast agents, it can be incorporated into standard clinical MRI protocols using existing hardware 24 . The successful clinical translation of APT imaging would reduce the misdiagnosis of tumor recurrence versus radiation necrosis and improve patient care.
RESULTS

Conventional MRI features of radiation necrosis and glioma
We first established a model of brain radiation necrosis in rats and evaluated its MRI characteristics on conventional T 2 -weighted and Gd-enhanced T 1 -weighted images, which are routinely used in the clinic. The left hemispheres of adult rats (Fischer 344; n = 10) were irradiated with a single dose of 40 Gy in an area of 10 × 10 mm 2 using a small animal radiation research platform 25 . One rat was killed in the animal care facility 101 d after the radiation exposure owing to severe eye infection. In all other rats, radiation-induced necrosis began to appear at ~5 months after radiation, and we acquired APT data during days 163−189. These rats developed large necrotic lesions that were heterogeneous on the T 2 -weighted images ( Fig. 1a ) and had high Gd enhancement on the post-contrast T 1 -weighted images ( Fig. 1b) . Necrotic lesions included several injured white matter tracts (fornix, external capsule, internal capsule and cerebral peduncle) and gray matter (caudate putamen).
We used two rat models of brain tumors (SF188/V+ and 9L) to compare viable neoplasm with radiation necrosis (Fig. 2) . The SF188/V+ xenografts are a human glioma model transfected with mouse full-length VEGF164 cDNA 26 . The SF188/V+ tumors grew in all rats (n = 9) with variable growth rates. We performed MRI 9−35 d after implantation, when the tumors were 3−5 mm in diameter. The SF188/V+ xenografts were quite heterogeneous on the T 2 -weighted images ( Fig. 2b) , similar to high-grade gliomas in humans. In addition, the tumor xenografts showed enhancement on the Gd-enhanced T 1 -weighted images. For the 9L gliosarcoma group (n = 9), we performed MRI 10−12 d after implantation, when the tumors were 3−5 mm in diameter. The 9L tumors were hyperintense on the T 2 -weighted images with large Gd enhancement ( Fig. 2c) . Therefore, as in the clinical situation ( Supplementary Fig. 1 ), radiation-induced necrosis and both brain tumor models had similar imaging features (T 2 abnormality, Gd enhancement and mass effect) that could generally not be used to distinguish between the different pathological processes.
Radiation necrosis and glioma can be differentiated by APT
The APT effect is measured as a reduction in bulk water intensity due to chemical exchange of water protons with labeled backbone amide protons of endogenous mobile proteins and peptides in tissue 20, 21 . Thus, specific molecular information is obtained indirectly through the bulk water signal that is usually used in imaging. Such labeling is accomplished using selective radiofrequency irradiation at the MR frequency of the backbone amide protons, ~3.5 p.p.m. downfield of the water resonance, causing saturation (or signal destruction) that is transferred to water protons 20, 21 . Typically, multiple saturation effects are ongoing in tissue, including direct water saturation and conventional magnetization transfer from semi-solid tissue components, and the APT signal must be separated out. The sum of all saturation effects is generally called the magnetization transfer ratio, MTR = 1 -S sat / S 0 , where S sat and S 0 are the signal intensities with and without selective irradiation. The APT signal is measured through referencing of the saturation effects at the amide proton frequency (+3.5 p.p.m. with respect to the water proton MR frequency) with effects at −3.5 p.p.m. from the water signal: MTR(+3.5 p.p.m.) -MTR(−3.5 p.p.m.). The resulting images are called the APT images.
We compared the appearance of APT images, Gd-enhanced T 1 -weighted images and histology in the radiation necrosis and tumor models ( Fig. 3) . We used Gd-enhanced T 1 -weighted images to identify lesions. These Gd-enhanced images appeared similar for all three pathologies, showing hyperintense areas that could be used to identify but not distinguish lesions. H&E staining of histological brain sections was performed to confirm the presence of radiation necrosis or viable tumors. In all cases of radiation necrosis, APT MRI signals were hypointense to isointense in the injured areas (as identified by Gd-enhanced T 1 -weighted images) with respect to the contralateral uninjured brain (Fig. 3a) . There were 'dark' necrotic cores with a hypointense APT signal (black arrow) in these injured areas. The necrotic cores corresponded to the centers of the Gdenhancing regions on the T 1 -weighted images. The Gd-enhanced regions extended outside the necrotic cores, where APT was isointense with respect to the contralateral brain tissue. Low-magnification histology images (1.25×) showed radiation-induced morphological changes, such as parenchymal coagulative necrosis (the cardinal characteristic of radiation necrosis). This necrotic change was found in the ipsilateral hemisphere, specifically in the white matter of the fornix, external capsule, internal capsule and cerebral peduncle. Highmagnification histology (20×) clearly showed the loss of normal brain tissue components with vacuolation changes of necrosis, particularly in the necrotic cores. Necrotic cells and damaged vessels were also seen in these regions. By contrast, APT imaging of both the SF188/V+ (Fig. 3b) and 9L (Fig. 3c ) tumors showed hyperintensities (pink arrow and red arrow, respectively) in the most viable, actively growing tumor areas, as identified by the Gd-enhanced T 1 -weighted images. Coronal histological sections clearly showed tumor masses, consisting of highdensity, relatively homogeneously distributed malignant cells. The tumor contours in the low-magnification (1.25×) histology images matched those in the Gd-enhanced T 1 -weighted and APT images. Furthermore, consistent with previous APT studies on animals 21 and humans 24 , the APT signals were consistently low in the peritumoral areas that did not have Gd enhancement, such as in the peritumoral edema and ventricles. Thus, APT hyperintensity is a unique feature of brain tumors. The above results show that, although radiationinduced necrosis and viable gliomas show similar T 2 hyperintense and Gd-enhanced MRI characteristics, they have markedly different APT images-namely hypointensity to isointensity for radiation necrosis (Fig. 3a) and hyperintensity for tumors (Fig. 3b,c) . This visible difference clearly indicates that the APT signal of endogenous cellular proteins and peptides can be used to distinguish active tumors from treatment-induced injury, such as radiation necrosis.
Quantitative analysis of APT MRI signal intensities
We compared the APT images of the two rat brain tumor models with radiation necrosis in a quantitative manner (Fig. 4) . In the radiationinjured brain, the average APT intensity was −3.6% ± 0.4% in Gdenhancing necrotic cores and −2.8% ± 0.3% in contralateral brain areas. Therefore, the APT MRI contrast between the necrotic cores and the contralateral brain tissue was small (−0.8%) but significant (95% confidence interval, −1.3% to −0.4%; P < 0.01; n = 9). In the SF188/V+ model, the average tumor APT signal was 12.2% ± 4.6%, which was significantly higher than that observed in the contralateral brain (−1.5% ± 0.6%; P < 0.001; n = 9). The average APT MRI contrast between tumor and contralateral brain tissue was 13.7% (95% confidence interval, 10.3% to 17.2%). In the 9L model, the APT imaging intensity also was significantly higher in the tumor (2.7% ± 0.7%) than in the contralateral brain tissue (−1.7% ± 0.9%; P < 0.001; n = 9), leading to an average APT contrast of 4.4%, with a 95% confidence interval of 3.7% to 5.1%.
The comparison showed that the average APT intensities of the two tumors were significantly higher than those of radiation-induced necrosis (all P < 0.001; Fig. 4 ). The APT contrast between SF188/V+ tumors and radiation necrosis was largest (15.8%, with a 95% confidence interval from 12.8% to 18.8%). For the 9L tumor, the APT contrast with radiation necrosis was 6.3% (95% confidence interval, 5.8% to 6.8%). The APT signals provide a reliable noninvasive imaging biomarker for the assessment of viable malignancy versus radiationinduced brain injury, which are often indistinguishable with routine MRI approaches (Supplementary Table 1) .
Distinguishing viable tumor from necrosis in a radiated tumor
We further applied APT imaging to rats with U87MG tumors (n = 5) that had been treated with radiation therapy. Within 1 d before radiation, we performed baseline MRI. On post-implantation day 11, when lesions were 4−7 mm in diameter, we irradiated the tumors with a single dose of 40 Gy to a 10 × 10 mm 2 region under image guidance with planar radiographs. We performed follow-up MRI 3 d and 6 d after radiation. At baseline, U87MG tumors were hyperintense with respect to contralateral brain tissue on APT images ( Fig. 5a and  Supplementary Fig. 2) . Although the irradiated tumors appeared to enlarge during the first several days after radiation, their APT signals gradually decreased following therapy, corresponding to a clear left shift of the APT histogram (Supplementary Fig. 3) . On postradiation day 6, the APT intensity of the irradiated tumors became quite heterogeneous (hyperintense to isointense). These irradiated Quantitatively, the average APT intensities of the U87MG tumors were 3.1% ± 0.3% before radiation, 2.1% ± 0.5% at 3 d after radiation and 0.6% ± 1.1% at 6 d after radiation (Fig. 5b) . This corresponds to a decrease in APT intensity of 1.1% (95% confidence interval, 0.6% to 1.6%; P < 0.05) at 3 d after radiation and 2.5% (95% confidence interval, 1.5% to 3.5%; P < 0.001) at 6 d after radiation. Several commonly used MRI parameters did not show significant changes during this early period after radiation ( Supplementary Table 2 ). Particularly, contrary to our expectation, there was a transient decrease in apparent diffusion coefficient (ADC) at 3 d after radiation. However, the mean ADC values in tumor increased at later time points, in line with preclinical and clinical data [28] [29] [30] (Supplementary Fig. 3 and  Supplementary Discussion) . These results clearly show that the APT signals could potentially provide an early, sensitive imaging biomarker for the evaluation of tumor response to radiation therapy.
DISCUSSION
Many types of tumor cells proliferate rapidly and have a higher cellular content of proteins and peptides than normal cells. A recent MRI-proteomics correlation experiment 22 showed that protein expression profiles correlated with Gd enhancement in human glioblastoma multiforme. More protein species and higher protein expression levels were seen in Gd-enhancing regions than in nonenhancing regions. Single-voxel, in vivo proton magnetic resonance spectroscopy results 23 have shown that the magnetic resonance spectroscopy-detectable mobile macromolecular proton concentration was higher in human brain tumors than in normal white matter and increased with tumor grade. APT MRI expands the range of molecular MRI techniques by allowing indirect detection of the amide proton signals in the backbone of endogenous proteins and peptides. According to current theory (Supplementary Methods) , the APT imaging signal in tissue is primarily related to two factors: the mobile amide proton content and the amide proton exchange rate, a parameter that depends on tissue pH. Fortunately, despite a low extracellular pH, only a small intracellular pH change (an increase of < 0.1 unit) is often detected in tumor tissue 31, 32 , allowing the increased APT intensities in tumors to be attributed mainly to increased cytosolic protein and peptide content.
Radiation-induced injury can have many manifestations, both clinically and pathologically 33 . There are three widely recognized syndromes: acute radiation toxicity (occurring during or immediately after radiation); subacute toxicity (occurring up to 6 months after radiation); and late toxicity (6 months to several years after radiation). All of these pathologies show a signal abnormality on T 2 -weighted or FLAIR images and new or increasing amounts of Gd enhancement in the area of radiation, which are indistinguishable from tumor recurrence. The low APT MRI signals in the necrotic lesions are probably associated with the absence of mobile cytosolic proteins and peptides owing to the loss of the cytoplasm. Tumors, conversely, are highly cellular, showing hyperintensities on APT images. Thus, the APT signals are a useful imaging biomarker for the presence of tumors but are not very sensitive to radiation necrosis. Our results show that APT MRI can provide key complementary information that should greatly improve the value of MRI in the differential diagnosis between viable tumors and radiation injury in humans (Supplementary Discussion).
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/.
Note: Supplementary information is available on the Nature Medicine website.
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